Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Multicenter Open Label Phase 2 Study of Isatuximab Plus Pomalidomide and Dexamethasone With Carfilzomib in Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT04287855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Clinical Outcomes in Patients With Relapsed/Refractory Multiple Myeloma (RRMM) Treated With T-cell Redirectors Outside of Clinical Trials
ClinicalTrials.gov study NCT06285318. IPD Sharing: NO. Countries: 11. Publications: 0.
Plerixafor and Filgrastim Following Cyclophosphamide for Stem Cell Mobilization in Patients With Multiple Myeloma
ClinicalTrials.gov study NCT01074060. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Daratumumab With DCEP for Multiple Myeloma With Plasmacytoma
ClinicalTrials.gov study NCT04065308. IPD Sharing: YES. Countries: 1. Publications: 0.
Simvastatin in Overcoming Chemotherapy Resistance in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT02971410. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Afuresertib Monotherapy in Japanese Relapsed Multiple Myeloma Patients
ClinicalTrials.gov study NCT02177682. IPD Sharing: NO. Countries: 1. Publications: 0.
Free From Maintenance Drug Therapy in Multiple Myeloma (The FREEDMM Trial) for Minimal Residual Disease (MRD
ClinicalTrials.gov study NCT05192122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients
ClinicalTrials.gov study NCT03618602. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
ClinicalTrials.gov study NCT03127761. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Study of DFRF4539A in Patients With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01432353. IPD Sharing: Not stated. Countries: 1. Publications: 0.
BCMA-targeted LCAR-BCDR Cells in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05376345. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05719701. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by Isatuximab and Lenalidomide Maintenance in Newly Diagnosed Patients With Multiple Myeloma a
ClinicalTrials.gov study NCT05147493. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma
ClinicalTrials.gov study NCT05344833. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib in Combination With CC-5013 in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00153933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
ClinicalTrials.gov study NCT02922543. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Learn About the Study Medicine (Maplirpacept) in People With Advanced Non-Hodgkin Lymphoma or Multiple Myeloma in China
ClinicalTrials.gov study NCT05896774. IPD Sharing: NO. Countries: 1. Publications: 0.
Radioimmunotherapy (211At-OKT10-B10) and Chemotherapy (Melphalan) Before Stem Cell Transplantation for the Treatment of Multiple Myeloma
ClinicalTrials.gov study NCT04466475. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Azacitidine to Treat Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT00412919. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT01182233. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.